New research published in the Canadian Journal of Cardiology suggests that Pradaxa and Xarelto bleeding risks may be no different than those of Warfarin (Coumadin). The study – conducted at Southlake Regional Health Centre in Ontario– examined 901 patients who took Warfarin and newer anticoagulants Pradaxa and Xarelto. After looking... Read more »

A motion to establish a multidistrict litigation (MDL) encompassing a growing number of Xarelto bleeding injury lawsuits will be heard on December 4 before the U.S. Judicial Panel on Multidistrict Litigation. The judges who are part of the panel will consider the merits of forming the MDL as a response... Read more »

The Janssen unit of Johnson & Johnson recently announced a Xarelto recall due to the discovery of a microbial contamination. To date, information regarding the exact nature of the contamination has not been released and so far it appears that no patients have suffered an illness because of the problem.... Read more »

Plaintiffs across the country have filed at least 21 Xarelto lawsuits against the maker of the popular blood thinner. The product liability lawsuits have been filed in 10 separate federal district courts. A group of the federal plaintiffs have now filed a motion for transfer requesting that the U.S. Judicial... Read more »

An 87-year-old California man has filed a Xarelto injury lawsuit against Janssen Research & Development, a subsidiary of Johnson & Johnson, and Bayer Healthcare after experiencing adverse side effects as a result of ingesting the drug. Allen Grossman allegedly suffered inter alia life-threatening bleeding and other severe and personal injuries... Read more »

A Tennessee family filed a Xarelto fatal bleed lawsuit in the U.S. District Court for the Eastern District of New York on August 14, 2014. The case is one of many against drug manufacturer Janssen, a subsidiary of Johnson & Johnson. In the first quarter of 2013, the 680 formal... Read more »